BRAF-Related In Vivo Models
Discover our comprehensive platform of CDX and PDX tumor models, carrying BRAF mutations across multiple cancer types:
- 18 CDX models carrying BRAF mutation (V600E, G469A, G464V, G466V, G596R or N581Y), covering melanoma, breast cancer, lung cancer and colorectal cancer
- 18 PDX models carrying BRAF mutation (V600E, G469A, G469E, D594N or N581S), covering melanoma, pancreatic cancer, lung cancer, head & neck cancer, colorectal cancer and lymphoma
- Case studies of BRAF and MEK inhibitor evaluation in tumor models carrying Class I, II or III BRAF mutations
BRAF related in vivo models-OncoWuXi Newsletter
Related Content
What if a constructed PROTAC with a confirmed high-affinity warhead doesn't work as expected? That means we need to take...
VIEW RESOURCEFragment-based drug discovery (FBDD) is one of the most well-developed approaches for projects starting from small, low-affinity compounds. At the...
VIEW RESOURCE